Volume 30, Number 1—January 2024
Research
Doxycycline Prophylaxis for Skin and Soft Tissue Infections in Naval Special Warfare Trainees, United States1
Jeffrey Spiro
, Piotr Wisniewski , Julia Schwartz, Alfred G. Smith, Sara Burger, Drake H. Tilley, and Ryan C. Maves
, Piotr Wisniewski , Julia Schwartz, Alfred G. Smith, Sara Burger, Drake H. Tilley, and Ryan C. Maves
Table 2
Wound and blood culture data from Naval Special Warfare trainees hospitalized for skin and soft tissue infections in the periods before and after implementation of doxycycline prophylaxis, United States
| Pathogen | Preprophylaxis | Postprophylaxis | ||
|---|---|---|---|---|
| Positive wound cultures | Positive blood cultures | Positive wound cultures | Positive blood cultures | |
| Staphylococcus aureus | 6 | 1 | 5 | 1 |
| Group A Streptococcus | 4 | 0 | 4 | 0 |
| Shewanella algae | 3 | 1 | 0 | 1 |
| Vibrio spp. | 2 | 1 | 1 | 0 |
| Coagulase-negative Staphylococcus | 2 | 0 | 1 | 1 |
| Staphylococcus lugdunensis | 1 | 0 | 0 | 0 |
| Diptheroids | 1 | 0 | 2 | 0 |
| Enterococcus faecalis | 2 | 0 | 0 | 1 |
| Acinetobacter hemolyticus | 2 | 0 | 0 | 0 |
| Pseudomonas aeruginosa | 1 | 0 | 0 | 0 |
| Providencia rettgeri | 0 | 0 | 1 | 0 |
1Preliminary findings were presented at IDWeek 2019, Washington, DC, USA, October 2–6, 2019.
Page created: November 07, 2023
Page updated: December 20, 2023
Page reviewed: December 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.